A detailed history of Cassady Schiller Wealth Management, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Cassady Schiller Wealth Management, LLC holds 3 shares of UTHR stock, worth $1,074. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3
Holding current value
$1,074
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025

BUY
$348.66 - $410.0 $1,045 - $1,230
3 New
3 $1,000
Q4 2022

Feb 13, 2023

BUY
$205.95 - $280.43 $205 - $280
1 New
1 $0

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.3B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Cassady Schiller Wealth Management, LLC Portfolio

Follow Cassady Schiller Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cassady Schiller Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cassady Schiller Wealth Management, LLC with notifications on news.